Braskem (BAK) EBT (2009 - 2025)

Braskem (BAK) has reported EBT for 16 consecutive years, with -$353.4 million the latest figure, recorded in Q1 2025.

• Quarterly EBT changed N/A year-over-year to -$353.4 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was -$534.7 million (changed N/A YoY) and the FY2025 annual result came in at -$527.7 million, up 82.71% from the prior year.
• EBT declined to -$353.4 million in Q1 2025 per BAK's latest filing, from $862.9 million in the prior quarter.
• Over the last five years, EBT for BAK reached as high as $862.9 million in Q4 2023 and fell as low as -$620.9 million in Q3 2023.
• A 4-year average of -$83.8 million and a median of -$272.7 million in 2022 frame the typical range for EBT.
• Annual changes were most pronounced in 2022 — EBT tumbled 289.17% — and 2023, when it jumped 303.85%.
• Year by year, EBT stood at $223.8 million in 2021, then tumbled by 289.17% to -$423.3 million in 2022, then soared by 303.85% to $862.9 million in 2023, then sank by 140.96% to -$353.4 million in 2025.
• According to Business Quant data, EBT over the past three periods registered -$353.4 million, $862.9 million, and -$620.9 million for Q1 2025, Q4 2023, and Q3 2023 respectively.